Clinigence Holdings (OTC:CLNH) and Nutex Health Holdco completed their business combination. The newly combined company, which will continue under the new name, Nutex Health, brings together two complementary healthcare organizations.
The common shares of Nutex Health have been approved for listing on NASDAQ and are expected to start trading under the new ticker symbol, NUTX, on April 4.
Under the combination, holders of membership interests in Nutex Holdco – primarily comprised of physician-owners who had prior to the merger contributed to Nutex Holdco all or a portion of their ownership interests in Nutex-affiliated hospitals – received an aggregate of 590,291,712 shares, representing approximately 92% shares outstanding of the newly combined company.
Nutex will be led by Tom Vo, M.D., as chairman and CEO, and Warren Hosseinion, M.D., as president. The board will consist of seven directors, of which four are independent appointees.
“We believe the combination of the resources of our two organizations is unique, and we are excited about our future,” Dr. Vo said in a statement. “We anticipate highly attractive growth opportunities ahead.”
Dr. Hosseinion said that as a physician-led integrated hospital system with risk-bearing provider networks, “we are committed to providing all of our patients with the most efficient and highest-quality care to ensure outstanding clinical, patient satisfaction and utilization outcomes.”
